Breathe Well Live Well
|
MediciNova Receives Notice of Patent Allowance for Method of Treating Acute …
NASDAQ SAN DIEGO, Dec. 9, 2012 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), … |
View full post on asthma – Google News
|
MediciNova Receives a Notice of European Patent Allowance for Treating …
NASDAQ MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis … MediciNova Receives Notice of European Patent Allowance for Treating … |
View full post on asthma – Google News